Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Risankizumab Versus Placebo in a Randomized, Double Blind, Parallel Group Trial in Moderate to Severe Plaque Psoriasis to Assess Safety and Efficacy After 16 Weeks of Treatment in the Russian Federation (IMMpress)
Brief Summary: The purpose of this study is to assess the safety and efficacy of risankizumab compared to placebo in subjects with moderate to severe chronic plaque psoriasis in the Russian Federation.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo for rizankizumab | Arm Label: Risankizumab; Type: EXPERIMENTAL; Interventions: Drug: risankizumab | Intervention Type: DRUG; Name: risankizumab; Assigned to Arm(s): Risankizumab | Intervention Type: DRUG; Name: placebo for rizankizumab; Assigned to Arm(s): Placebo
B: Arm Label: Active Treatment (10 mg) BID / Placebo BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Active Treatment (10 mg) BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Active Treatment (5 mg) BID / Placebo BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Arm Label: Active Treatment (5 mg) BID; Type: EXPERIMENTAL; Interventions: Drug: CP-690,550 | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment (10 mg) BID / Placebo BID | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment (10 mg) BID | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment (5 mg) BID / Placebo BID | Intervention Type: DRUG; Name: CP-690,550; Assigned to Arm(s): Active Treatment (5 mg) BID
C: Arm Label: Placebo 2 mL auto-injector; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo 2 mL auto-injector | Arm Label: Placebo 1 mL prefilled syringe; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo 1 mL prefilled syringe | Arm Label: Secukinumab 2 mL auto-injector; Type: EXPERIMENTAL; Interventions: Drug: Secukinumab 2 mL auto-injector | Arm Label: Secukinumab 1 mL prefilled syringe; Type: ACTIVE_COMPARATOR; Interventions: Drug: Secukinumab 1 mL prefilled syringe | Intervention Type: DRUG; Name: Placebo 2 mL auto-injector; Assigned to Arm(s): Placebo 2 mL auto-injector | Intervention Type: DRUG; Name: Placebo 1 mL prefilled syringe; Assigned to Arm(s): Placebo 1 mL prefilled syringe | Intervention Type: DRUG; Name: Secukinumab 2 mL auto-injector; Assigned to Arm(s): Secukinumab 2 mL auto-injector | Intervention Type: DRUG; Name: Secukinumab 1 mL prefilled syringe; Assigned to Arm(s): Secukinumab 1 mL prefilled syringe
D: Arm Label: CP 690,550 5 mg BID+Placebo BIW; Type: EXPERIMENTAL; Interventions: Drug: CP 690,550 5 mg | Arm Label: CP 690,550 10 mg BID+Placebo BIW; Type: EXPERIMENTAL; Interventions: Drug: CP 690,550 10 mg | Arm Label: Placebo BID+Etanercept 50 mg BIW; Type: ACTIVE_COMPARATOR; Interventions: Biological: Etanercept 50 mg | Arm Label: Placebo BID+Placebo BIW; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: CP 690,550 5 mg; Assigned to Arm(s): CP 690,550 5 mg BID+Placebo BIW | Intervention Type: DRUG; Name: CP 690,550 10 mg; Assigned to Arm(s): CP 690,550 10 mg BID+Placebo BIW | Intervention Type: BIOLOGICAL; Name: Etanercept 50 mg; Assigned to Arm(s): Placebo BID+Etanercept 50 mg BIW | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo BID+Placebo BIW

Answer: A